Profil bibliographique

Alison M. Lawrie

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

152Publications signalées

20980Citations signalées

2Affiliations récentes

Institutions déclarées

Mansfield University University of Oxford

Domaines associés

Malaria Research and ControlMosquito-borne diseases and controlvaccines and immunoinformatics approachesImmune responses and vaccinationsTuberculosis Research and Epidemiology

Publications récentes

Accès ouvert 2026 preprintOpenAlex

Safety, Tolerability, and Immunogenicity of NeomiVac, a Next-Generation mRNA–Lipid Nanoparticle Vaccine Comprising a Novel Ionisable Lipid: A First-In-Human, Phase 1, Dose-Escalation Trial

Angelica Vaccaro, Jordon Rolt, Nicole Frumento, Ola Diebold et autres

0 citationsSSRN Electronic Journal

Accès ouvert 2026 preprintOpenAlex

Preclinical Evaluation and Phase I Clinical Trial of Neomivac, a Lipid Nanoparticle mRNA Vaccine

Angelica Vaccaro, Jordon Rolt, Nicole Frumento, Ola Diebold et autres

0 citationsSSRN Electronic Journal

Accès ouvert 2025 articleOpenAlex

Safety, tolerability, and immunogenicity of the ChAdOx1 RVF vaccine against Rift Valley fever among healthy adults in Uganda: a single-centre, single-blind, randomised, placebo-controlled, dose-escalation, phase 1 trial

Zacchaeus Anywaine, Jennifer Serwanga, Abu-Baker Ggayi, Andrew Abaasa et autres

4 citationsThe Lancet Infectious Diseases

Accès ouvert 2025 articleOpenAlex

A phase 1b clinical trial to determine the safety, tolerability and immunogenicity of simian adenovirus and poxvirus vectored vaccines against a Mycobacterium avium complex subspecies in patients with active Crohn's disease

Jeremy Sanderson, Jeremy Aboagye, Rebecca Makinson, Katerina Rapi et autres

3 citationsEBioMedicine

Accès ouvert 2025 articleOpenAlex

Safety and immunogenicity of a bivalent Ebola virus and Sudan virus ChAdOx1 vectored vaccine in adults in the UK: an open-label, non-randomised, first-in-human, phase 1 clinical trial

Daniel Jenkin, Rebecca Makinson, Helen Sanders, Alex Sampson et autres

11 citationsThe Lancet Microbe

Accès ouvert 2025 articleOpenAlex

R21 in Matrix-M adjuvant in UK malaria-naive adult men and non-pregnant women aged 18–45 years: an open-label, partially blinded, phase 1–2a controlled human malaria infection study

Navin Venkatraman, Daniel Silman, Duncan Bellamy, Lisa Stockdale et autres

14 citationsThe Lancet Microbe

Accès ouvert 2024 articleOpenAlex

Phase I/IIa study to assess the safety, immunogenicity and efficacy of ChAdOx1-MVA vectored vaccines expressing a novel liver-stage malaria dual antigen LS2 by sporozoite challenge in malaria-naïve adults

Daniel Silman, Amy Flaxman, Mehreen S Datoo, Nick J. Edwards et autres

1 citationWellcome Open Research

Accès ouvert 2024 articleOpenAlex

Safety and efficacy of the blood-stage malaria vaccine RH5.1/Matrix-M in Burkina Faso: interim results of a double-blind, randomised, controlled, phase 2b trial in children

Hamtandi Magloire Natama, Jo Salkeld, Seyi Soremekun, Ousmane Traoré et autres

45 citationsThe Lancet Infectious Diseases

Accès ouvert 2024 preprintOpenAlex

Safety and efficacy of the blood-stage malaria vaccine RH5.1/Matrix-M in Burkina Faso: interim results of a double-blind, randomised, controlled phase 2b trial in children

Hamtandi Magloire Natama, Jo Salkeld, Seyi Soremekun, Ousmane Traoré et autres

1 citationmedRxiv

Accès ouvert 2024 articleOpenAlex

Blood-stage malaria vaccine candidate RH5.1/Matrix-M in healthy Tanzanian adults and children; an open-label, non-randomised, first-in-human, single-centre, phase 1b trial

Sarah E. Silk, Wilmina F. Kalinga, Jo Salkeld, Ivanny M. Mtaka et autres

45 citationsThe Lancet Infectious Diseases

Accès ouvert 2024 articleOpenAlex

Safety of a controlled human infection model of tuberculosis with aerosolised, live-attenuated Mycobacterium bovis BCG versus intradermal BCG in BCG-naive adults in the UK: a dose-escalation, randomised, controlled, phase 1 trial

Iman Satti, Julia L. Marshall, Stephanie A. Harris, Rachel Wittenberg et autres

30 citationsThe Lancet Infectious Diseases

Accès ouvert 2024 preprintOpenAlex

First Phase 1b, single-center, age de-escalation trial of the P. falciparum blood-stage malaria vaccine candidate RH5.1/Matrix-M ™ : a delayed boost regimen induces high levels of functional antibodies in 5-17 month old Tanzanian infants

Sarah E. Silk, Wilmina F. Kalinga, Jo Salkeld, Ivanny M. Mtaka et autres

0 citationsmedRxiv

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.